Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company is operating in a highly competitive and fragmented segment of health care services and providing related equipment. It has posted de-growth in its top and bottom lines for the reported periods. Based on FY24 earnings, the issue appears exorbitantly priced. There is no harm in skipping this “High Risk/Low Return” pricey bet. Read detail review...
Aprameya Engineering Limited peer comparison with similar listed entities. (As on March 31, 2024)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Aprameya Engineering Limited | 3.84 | 3.84 | 16.69 | 15.12 | 14.79 | 3.48 |
Aprameya Engineering IPO Reviews, analysis and views by popular members. Read Aprameya Engineering Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
Useful Articles
RHP